Rehabilitation management of peripheral neuropathy

Seminars in Neurology

Volumn 25, Issue 2, 2005, Pages 229-237

  Carter, Gregory T ^a,b  

^a School of Medicine ^*  (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Neuromuscular disease; Neuropathic pain; Orthotics; Peripheral neuropathy; Rehabilitation

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; BUPIVACAINE; CANNABINOID; CARBAMAZEPINE; GABAPENTIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; MORPHINE SULFATE; NORTRIPTYLINE; OPIATE; OXYCODONE; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; TIAGABINE; TOPIRAMATE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE; ZONISAMIDE;

BRACE; CLINICAL TRIAL; COOPERATION; DAILY LIFE ACTIVITY; DEFORMITY; EXERCISE; FUNCTIONAL ASSESSMENT; HUMAN; LOCOMOTION; NEUROPATHIC PAIN; NURSE; ORTHOPEDIC EQUIPMENT; ORTHOPEDIC SURGERY; ORTHOTICS; PERIPHERAL NEUROPATHY; PHYSICIAN; PHYSIOTHERAPIST; PRIORITY JOURNAL; PSYCHOLOGIST; REVIEW; SAFETY; SIDE EFFECT; TREATMENT PLANNING; VOCATIONAL GUIDANCE;

BRACES; EDUCATION, MEDICAL, CONTINUING; HUMANS; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; SHOES;

EID: 20544441057     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871331     Document Type: Review

References (68)

1. Emery AH. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord 1991; 1:19-29
2. Carter GT, Abresch RT, Fowler WM, et al. Profiles of neuromuscular disease: hereditary motor and sensory neuropathy, types I and II. Am J Phys Med Rehabil 1995;74:S140-S149
3. Carter GT. Neuromuscular disorders. In: Dell Orto AE, Marinelli RP, eds. Encyclopedia of Disability and Rehabilitation. New York: Simon & Schuster MacMillan; 1995:509-515
4. Fowler WM, Abresch RT, Aitkens SA, Carter GT. Impairment and disability profiles of neuromuscular diseases: design of the protocol. Am J Phys Med Rehabil 1995;74:62-69
5. Fowler WM, Carter GT, Kraft GH. Role of physiatry in the management of neuromuscular disease. Phys Med Rehabil Clin N Am 1998;9:1-8
6. Carter GT. e-Medicine: rehabilitation management of neuromuscular disease. Physical Medicine and Rehabilitation. Available at: www.emedicine.com/pmr/topic233.htm
7. Carter GT, England JD, Hecht TW, Han J, Weydt P, Chance P. Electrodiagnosis of hereditary motor and sensory neuropathies. Phys Med Rehabil Clin N Am 2003;14:347-363
8. Carter GT, England JD, Chance PF. Charcot-Marie-Tooth disease: electrophysiology, molecular biology, and clinical management. IDrugs 2004;7:151-159
9. Ionasescu VV. Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics. Muscle Nerve 1995;18:267-275
10. Lindeman E, Leffers P, Reulen J, Spaans F, Drukker J. Quadriceps strength and timed motor performances in myotonic dystrophy, Charcot-Marie-Tooth disease, and healthy subjects. Clin Rehabil 1998;12:127-135
11. Lindeman E, Leffers P, Reulen J, et al. Reduction of knee torques and leg-related functional abilities in hereditary motor and sensory neuropathy. Arch Phys Med Rehabil 1994;75: 1201-1205
12. Kilmer DD, Aitkens SG, Wright NC, et al. Simulated work performance tasks in persons with neuropathic and myopathic weakness. Arch Phys Med Rehabil 2000;81:938-943
13. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effects in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1993;74:711-715
14. Kilmer DD, McCrory MA, Wright NC, Aitkens SG, Bernauer EM. The effect of a high resistance exercise program in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1994;75:560-563
15. Kilmer DD. Response to aerobic exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 2002; 81:5148-5150
16. Kilmer DD. Response to resistive strengthening exercise training in humans with neuromuscular disease. Am J Phys Med Rehabil 2002;81:S121-S126
17. Kilmer DD. The role of exercise in neuromuscular disease. Phys Med Rehabil Clin N Am 1998;9:115-125
18. Lindeman E, Leffers P, Spaans F, et al. Strength training in patients with myotonic dystrophy and hereditary motor and senson' neuropathy: a randomized clinical trial. Arch Phys Med Rehabil 1995;76:612-620
19. Kilmer DD, Mcrory MA, Wright NC, et al. Hand held dynamometry reliability in persons with neuropathic weakness. Arch Phys Med Rehabil 1997;78:1364-1368
20. Carter GT, Kikuchi N, Abresch RT, Walsh SA, Horasek S, Fowler WM. Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehabil 1994;75:555-559
21. Carter GT, Abresch RT, Fowler WM. Adaptations to exercise training and contraction-induced muscle injury in animal models of neuromuscular disease. Am J Phys Med Rehabil 2002;81(suppl):S151-S161
22. Breslin E, Booth J, Lord B, et al. Respiratory responses to unsupported arm exercise (UAE) in Charcot Marie Tooth (CMT) [abstract]. American Thoracic Society. Am Rev Respir Dis 1993;147:A532
23. Breslin EH, Carter GT, Mercer K, Bonekat HW, Lee K. Fatigue in patients with Charcot-Marie-Tooth [abstract]. Arch Phys Med Rehabil 1993;74:A1256-A1257
24. Videler AJ, Beelen A, Aufdemkampe G, et al. Hand strength and fatigue in patients with hereditary motor and sensory neuropathy (types I and II). Arch Phys Med Rehabil 2002;83:1274-1278
25. Carter GT, Kilmer DD, Szabo RM, McDonald CM. Focal posterior interosseus neuropathy in the presence of hereditary motor and sensory neuropathy, type I. Muscle Nerve 1996; 19:644-648
26. McDonald CM. Limb contracture in progressive neuromuscular disease and the role of stretching, orthotics, and surgery. Phys Med Rehabil Clin N Am 1998;9:187-212
27. Paulson LE, Kilmer DD. Orthotic management in peripheral neuropathy. Phys Med Rehabil Clin N Am 2001;12:433-445
28. Boninger ML, Leonard JA Jr. Use of bivalved ankle-foot orthosis in neuropathic foot and ankle lesions. J Rehabil Res Dev 1996;33:16-19
29. Bean J, Walsh A, Frontera W. Brace modification improves aerobic performance in Charcot-Marie-Tooth disease: a single-subject design. Am J Phys Med Rehabil 2001;80: 578-582
30. Perry J. Normal and pathological gait. In: Goldberg B, Hsu JD, eds. Atlas of Orthoses and Assistive Devices. 3rd ed. St. Louis: Mosby; 1997:295-304
31. Helm PA, Walker SC, Pullium G. Total contact casting in diabetics with neuropathic foot ulcerations. Arch Phys Med Rehabil 1984;65:691-695
32. Helm PA, Walker SC, Pullium GF. Recurrence of neuropathic ulceration following healing in a total contact cast. Arch Phys Med Rehabil 1991;72:967-975
33. King S, Thomas JJ, Rice MS. The immediate and short-term effects of a wrist extension orthosis on upper-extremity kinematics and range of shoulder motion. Am J Occup Ther 2003;57:517-524
34. Schon LC, Easley ME, Weinfeld SB. Charcot neuroarthropathy of the foot and ankle. Clin Orthop 1998;349:116-117
35. Sella EJ, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999;38:34-45
36. Sinacore DR, Withrington NC. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther 1999;29:736-741
37. Walker SC, Helm PA, Pullium G. Total contact casting and chronic diabetic neuropathic foot ulcerations: healing rates by wound location. Arch Phys Med Rehabil 1987;68:217-223
38. Mehta JA, Brown C, Sargeant N. Charcot restraint orthotic walker. Foot Ankle Int 1998;19:619-624
39. Morgan JM, Biehl WC III, Wagner FW. Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop 1993;296:58-64
40. Carter GT, Jensen MP, Galer BS, et al. Neuropathic pain in Charcot Marie Tooth disease. Arch Phys Med Rehabil 1998;79:1560-1564
41. Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A. Pain in Guillain-Barre syndrome. Neurology 1997;48:328-331
42. Carter GT, Galer BS. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 2001;12: 447-460
43. Abresch RT, Jensen MP, Carter GT. Health quality of life in peripheral neuropathy. Phys Med Rehabil Clin N Am 2001; 12:461-472
44. Abresch RT, Carter GT, Jensen MP, Kilmer DD. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care 2002;19:39-48
45. Backonja MM. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Epilepsia 1999;40:S57-S59
46. Beydoun A. Postherpetic neuralgia: role of gabapentin and other treatment modalities. Epilepsia 1999;40:S51-S56
47. Magnus L. Nonepileptic uses of gabapentin. Epilepsia 1999; 40:S66-S72
48. McQuay H, Carroll D, Jadad AR, et al. Anticonvulsant drugs for management of pain: a systemic review. BMJ 1995;311: 1047-1052
49. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999;159:1931-1937
50. Carter GT, Sullivan MD. Antidepressants in pain management. Curr Opin Investig Drugs 2002;3:454-458
51. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73:123-139
52. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal depressed mood. Neurology 1987;37:589-596
53. Max MB, Lynch SA, Muir J, et al. Effects of desipramine, arnitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1252
54. Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998;51:1166-1171
55. Taylor K, Rowbotham MC. Venlafaxine hydrochloride and chronic pain. West J Med 1996;165:147-148
56. Galer BS, Harle J, Rowbotham MC. Response to intravenous lidocaine infusion predicts subsequent response to oral mexilitine: a prospective study. J Pain Symptom Manage 1996;12:161-167
57. Galer BS, Miller KV, Rowbotham MC. Response to intravenous lidocaine differs based on clinical diagnosis and site of nervous system injury. Neurology 1993;43:1233-1235
58. Galer BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology 1995;45:17-25
59. Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle patch: results of an enriched enrollment study. Pain 1999;80:533-538
60. Galer BS. Painful polyneuropathy. Neurol Clin 1998;16:791-812
61. Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004;(2): CD003726
62. Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998;50:1837-1841
63. Jay C, Shade S, Vizoso H, et al. The effect of smoked marijuana on chronic neuropathic and experimentally induced pain in HIV neuropathy: results of an open-label pilot study. Proceedings of the 11th Conference on Retroviruses and Opportunistic Infections 2004;496:A243 (Abstract)
64. Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 2003;17:21-29
65. Carter GT, Rosen BS. Marijuana in the management of amyotrophic lateral sclerosis. Am J Hosp Palliat Care 2001; 18:264-270
66. Carter GT, Weydt P. Cannabis: old medicine with new promise for neurological disorders. Curr Opin Investig Drugs 2002;3:437-440
67. Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry 2001;178:98-105
68. Rice ASC. Cannabinoids and pain. Curr Opin Investig Drugs 2001;2:399-414